🔍 The process effectively separates mRNA from impurities with high yields and purity, while minimizing space requirements.
💡 Ongoing work aims to recover valuable contaminants, advancing mRNA production techniques. This breakthrough may reshape the industry!
Introduction:
This article discusses a novel approach developed by researchers at the Massachusetts Institute of Technology (MIT) for the purification of messenger RNA (mRNA) using a simplified continuous precipitation method. This advancement aims to enhance the efficiency and reduce the complexity of mRNA manufacturing processes, which are critical in various biomedical applications, including vaccine development.
- The newly developed mRNA purification process employs continuous precipitation to isolate mRNA while allowing impurities to remain in solution.
- This method utilizes two tangential flow filters—one for impurity removal and another for precipitating agent extraction and buffer exchange.
- The use of a combination of salts and polyethylene glycol facilitates the separation of larger mRNA molecules from smaller impurities.
- The technique shows promise for commercial-scale application, producing yields of 90% with 97% purity without degrading mRNA or allowing impurities like double-stranded RNA.
- The research team is exploring ways to recover valuable enzymes and nucleotides during the purification process, rather than discarding them, potentially generating additional benefits.
Conclusion:
The MIT team’s innovation in mRNA purification through continuous precipitation not only simplifies the downstream processing but also enhances cost-efficiency, promising to improve large-scale mRNA production. As this method moves closer to commercial implementation, it has the potential to revolutionize manufacturing in the biopharmaceutical industry and optimize the use of biological resources.
